[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"stage-1-hypertension\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:stage-1-hypertension":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":24,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100632585",false,"NCT07515599","Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension","A Prospective, Multi-Center, Observational Study to Evaluate the Efficacy of OLMETEC Tab. (or OLMETEC Plus Tab.) on Nocturnal Blood Pressure Control in Korean Patients With Stage Ⅰ Hypertension","Inclusion Criteria:\n\n* Adults aged ≥19 years\n* Patients diagnosed with stage 1 hypertension according to clinical guidelines\n* Patients who are newly prescribed Olmetec® or Olmetec Plus® in routine -clinical practice\n* Patients who are able to undergo ambulatory blood pressure monitoring (ABPM)\n* Patients who voluntarily agree to participate and provide written informed consent\n\nExclusion Criteria:\n\n* Patients with secondary hypertension\n* Patients with severe hypertension requiring immediate pharmacological i-ntervention\n* Patients with known hypersensitivity to olmesartan medoxomil, hydrochlorothiazide, or any component of the study drugs\n* Patients who are pregnant, planning to become pregnant, or breastfeeding\n* Patients with severe renal impairment or severe hepatic impairment\n* Patients who are unable to comply with study procedures, including ABPM\n* Patients who are deemed inappropriate for participation by the investigator","ALL","19 Years",{"count":18,"type":19},12000,"ESTIMATED","OBSERVATIONAL","This is a prospective, multicenter, observational study to evaluate the effectiveness of Olmetec® or Olmetec Plus® on nocturnal blood pressure control in Korean patients with stage 1 hypertension. Patients receiving Olmetec-based therapy in routine clinical practice will be followed to assess changes in ambulatory blood pressure, including nocturnal blood pressure and blood pressure variability.",[23],"Stage 1 Hypertension",[25],"hypertension","RECRUITING","2026-03-31",{"date":29,"type":30},"2026-04-07","ACTUAL",{"date":32,"type":30},"2025-09-17",{"date":34,"type":19},"2027-01-31",{"name":36,"class":37},"Daewoong Pharmaceutical Co. LTD.","INDUSTRY",""]